Cargando…
Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764469/ https://www.ncbi.nlm.nih.gov/pubmed/33373651 http://dx.doi.org/10.1016/j.jinf.2020.12.021 |
| _version_ | 1783628264324988928 |
|---|---|
| author | Chan, Huan-Tee Chao, Chien-Ming Lai, Chih-Cheng |
| author_facet | Chan, Huan-Tee Chao, Chien-Ming Lai, Chih-Cheng |
| author_sort | Chan, Huan-Tee |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7764469 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77644692020-12-28 Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis Chan, Huan-Tee Chao, Chien-Ming Lai, Chih-Cheng J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-04 2020-12-26 /pmc/articles/PMC7764469/ /pubmed/33373651 http://dx.doi.org/10.1016/j.jinf.2020.12.021 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Chan, Huan-Tee Chao, Chien-Ming Lai, Chih-Cheng Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis |
| title | Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis |
| title_full | Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis |
| title_fullStr | Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis |
| title_full_unstemmed | Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis |
| title_short | Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis |
| title_sort | sofosbuvir/daclatasvir in the treatment of covid-19 infection: a meta-analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764469/ https://www.ncbi.nlm.nih.gov/pubmed/33373651 http://dx.doi.org/10.1016/j.jinf.2020.12.021 |
| work_keys_str_mv | AT chanhuantee sofosbuvirdaclatasvirinthetreatmentofcovid19infectionametaanalysis AT chaochienming sofosbuvirdaclatasvirinthetreatmentofcovid19infectionametaanalysis AT laichihcheng sofosbuvirdaclatasvirinthetreatmentofcovid19infectionametaanalysis |